Literature DB >> 18790305

35 years of Japanese policy on rare diseases.

Shuichiro Hayashi, Tamami Umeda.   

Abstract

Mesh：

Year:  2008        PMID： 18790305     DOI： 10.1016/S0140-6736(08)61393-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  Rare inherited kidney diseases: challenges, opportunities, and perspectives.

Authors:  Olivier Devuyst; Nine V A M Knoers; Giuseppe Remuzzi; Franz Schaefer
Journal:  Lancet       Date:  2014-05-24       Impact factor: 79.321

Review 2.  Innovative measures to combat rare diseases in China: The national rare diseases registry system, larger-scale clinical cohort studies, and studies in combination with precision medicine research.

Authors:  Peipei Song; Jiangjiang He; Fen Li; Chunlin Jin
Journal:  Intractable Rare Dis Res       Date:  2017-02

3.  Genetic Testing for Rare Diseases.

Authors:  José M Millán; Gema García-García
Journal:  Diagnostics (Basel)       Date:  2022-03-25

4.  Duration of prion disease is longer in Japan than in other countries.

Authors:  Kiwamu Nagoshi; Atsuko Sadakane; Yosikazu Nakamura; Masahito Yamada; Hidehiro Mizusawa
Journal:  J Epidemiol       Date:  2011-05-28       Impact factor: 3.211

5.  Trends in orphan drug use and spending among children and adolescents during 2010-2020 in Korea.

Authors:  Jung Yeon Oh; Jin Yong Lee; Dong-Sook Kim
Journal:  Front Pharmacol       Date:  2022-08-31       Impact factor: 5.988

6.  A population-based registry as a source of health indicators for rare diseases: the ten-year experience of the Veneto Region's rare diseases registry.

Authors:  Monica Mazzucato; Laura Visonà Dalla Pozza; Silvia Manea; Cinzia Minichiello; Paola Facchin
Journal:  Orphanet J Rare Dis       Date:  2014-03-19       Impact factor: 4.123

7.  Specific clinical signs and symptoms are predictive of clinical course in sporadic Creutzfeldt-Jakob disease.

Authors:  E Nakatani; Y Kanatani; H Kaneda; Y Nagai; S Teramukai; T Nishimura; B Zhou; S Kojima; H Kono; M Fukushima; T Kitamoto; H Mizusawa
Journal:  Eur J Neurol       Date:  2016-05-24       Impact factor: 6.089

8.  National Registry of Designated Intractable Diseases in Japan: Present Status and Future Prospects.

Authors:  Yasuhiro Kanatani; Naoko Tomita; Yoko Sato; Akiko Eto; Hiroe Omoe; Hiroshi Mizushima
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-09-21       Impact factor: 1.742

9.  The collective impact of rare diseases in Western Australia: an estimate using a population-based cohort.

Authors:  Caroline E Walker; Trinity Mahede; Geoff Davis; Laura J Miller; Jennifer Girschik; Kate Brameld; Wenxing Sun; Ana Rath; Ségolène Aymé; Stephen R Zubrick; Gareth S Baynam; Caron Molster; Hugh J S Dawkins; Tarun S Weeramanthri
Journal:  Genet Med       Date:  2016-09-22       Impact factor: 8.822

10.  Disease and economic burden for rare diseases in Taiwan: A longitudinal study using Taiwan's National Health Insurance Research Database.

Authors:  Jason C Hsu; Huai-Chueh Wu; Wen-Chia Feng; Chih-Ho Chou; Edward Chia-Cheng Lai; Christine Y Lu
Journal:  PLoS One       Date:  2018-09-21       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.